Provided by Tiger Trade Technology Pte. Ltd.

Gelteq

0.5628
+0.00530.94%
Post-market: 0.5272-0.0356-6.33%19:44 EDT
Volume:21.04K
Turnover:11.46K
Market Cap:6.29M
PE:-1.20
High:0.5890
Open:0.5890
Low:0.5366
Close:0.5576
52wk High:2.02
52wk Low:0.3870
Shares:11.18M
Float Shares:5.15M
Volume Ratio:0.81
T/O Rate:0.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4690
EPS(LYR):-0.4699
ROE:-42.93%
ROA:-17.61%
PB:0.62
PE(LYR):-1.20

Loading ...

Company Profile

Company Name:
Gelteq
Exchange:
NASDAQ
Establishment Date:
2017
Employees:
- -
Office Location:
Monash Innovation Labs,G.60, 22 Alliance Lane,Clayton,Victoria,Australia
Zip Code:
3800
Fax:
- -
Introduction:
Gelteq Limited was incorporated on October 15, 2018, under the laws of Victoria, Australia. It is a clinically and scientifically based company specializing in "white label" gel delivery solutions for prescription pharmaceuticals, nutraceuticals, pet care, and other products, which other companies rebrand as their own. Their core product is edible gels and gel-based dosage forms, spanning five key verticals—pet, sports, pharmaceutical, over-the-counter (OTC), and nutraceuticals—all utilizing patent-pending multi-component dosage forms. Their current focus is licensing the technology to companies to develop new products for established markets while continuing to manufacture existing products on a white-label basis.

Directors

Name
Position
Nathan J. Givoni
Chief Executive Officer and Director
Philip A. Dalidakis
Independent Director
Simon H. Szewach
Director

Shareholders

Name
Position
Nathan J. Givoni
Chief Executive Officer and Director
Thuy Linh Gigler
Chief Financial Officer
Paul M. Wynne
Chief Scientific Officer